Substance Use Treatment in Philadelphia, PA

Behavorial Center at Girard

What Does Behavorial Center at Girard Offer?

Behavorial Center At Girard is a substance use treatment facility at 801 West Girard Avenue, GMC Building, 3 North, Philadelphia, Pennsylvania, offering hospital inpatient care. It accepts Medicaid and state-financed insurance. Medication treatment: buprenorphine and naltrexone.

Reviewed by Michael Rupe ·October 2, 2026

801 West Girard Avenue, GMC Building, 3 North
Philadelphia, PA 19122

Listed in SAMHSA's FindTreatment.gov, checked October 2026. A listing is not an endorsement. Call to confirm services, openings and costs before you go.

Loading map…

Treatment facility (SAMHSA listing)This facility

Types of Care at Behavorial Center at Girard

Hospital inpatient/24-hour hospital inpatient
Hospital inpatient treatment

Payment, Insurance and Help Paying

Medicaid
State-financed health insurance plan other than Medicaid
SAMHSA funding/block grants

Medication Treatment

Buprenorphine maintenance
Prescribes buprenorphine
Prescribes naltrexone
Relapse prevention with naltrexone
Accepts clients using MAT but prescribed elsewhere
Lofexidine or Clonidine detoxification
Maintenance service with medically supervised withdrawal after stabilization
Buprenorphine with naloxone
Buprenorphine without naloxone
Naltrexone (oral)
Clonidine

Who the Program Serves

Young adults
Adult women
Adult men
Seniors or older adults
Veterans
Clients with co-occurring mental and substance use disorders
Clients with HIV or AIDS
Clients who have experienced sexual abuse
Clients who have experienced intimate partner violence, domestic violence
Clients who have experienced trauma
Ages: Young Adults
Ages: Adults
Ages: Seniors
Accepts: Female
Accepts: Male

Language Services

Sign language services for the deaf and hard of hearing
Spanish

Licensing and Accreditation

State substance use treatment agency
State mental health department
State department of health
Hospital licensing authority
The Joint Commission
Drug Enforcement Agency (DEA)

Treatment Approaches

Anger management
Brief intervention
Cognitive behavioral therapy
Contingency management/motivational incentives
Community reinforcement plus vouchers
Motivational interviewing
Matrix Model
Relapse prevention
Substance use disorder counseling
Telemedicine/telehealth therapy
Trauma-related counseling
12-step facilitation

Assessment, Recovery Support and Other Services

Comprehensive mental health assessment
Comprehensive substance use assessment
Outreach to persons in the community
Complete medical history/physical exam
Screening for tobacco use
Screening for substance use
Screening for mental disorders
Professional interventionist/educational consultant
Aftercare/continuing care
Discharge Planning
Naloxone and overdose education
Outcome follow-up after discharge
Self-help groups
Housing services
Assistance with obtaining social services
Mentoring/peer support
Mental health services
Social skills development
Integrated primary care services
Suicide prevention services
Breathalyzer or blood alcohol testing
Drug and alcohol oral fluid testing
Drug or alcohol urine screening
HIV testing
STD testing
TB screening
Metabolic syndrome monitoring
Testing for Hepatitis B (HBV)
Testing for Hepatitis C (HCV)
Hepatitis A (HAV) vaccination
Hepatitis B (HBV) vaccination
Treatment for other addiction disorder

Before you commit, confirm openings, costs and the program's state license. How to choose a rehab you can trust lists the questions to ask when you call, and addiction treatment in Pennsylvania lists the state's treatment agency.